go-v.orgdoi

Two-Sample Network Mendelian Randomization and Single-Cell Analysis Reveal the Causal Associations and Underlying Mechanisms Between Antihypertensive Drugs and Kidney Cancer

Ruiyi Deng, Mingrui Zou, Jianhui Qiu, Jiaheng Shang, Chaojian Yu, Peidong Tian, Yizhou Wang, Lin Cai, Jingcheng Zhou, Kan Gong · Journal of Cancer · 2025

  • DOI 10.7150/jca.110850
  • Publisher Ivyspring International Publisher
  • Type article
  • Issued 2025

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Journal of Cancer · Ivyspring International Publisher · article · 2025

Abstract

Background: Antihypertensive drugs represent the most widely used drugs worldwide.However, the association between antihypertensive drugs and the risk of kidney cancer remains unclear.This study innovatively integrates multi-omics and causal inference approaches to investigate the long-term effects and potential mechanisms of 12 antihypertensive drug classes on kidney cancer risk.Methods: In this study, novel approaches including two-sample mendelian randomization (MR), summary-data-based mendelian randomization (SMR), two-step network MR, and single-cell transcriptomic analysis were employed.Single nucleotide polymorphisms (SNPs) were obtained from genome-wide association studies (GWASs) to proxy exposures and outcomes.The cis-expression quantitative trait loci (cis-eQTL) as the proxies of exposure were also obtained.MR estimates were generated using the inverse-variance weighted method or Wald ratio method.Sensitivity analyses were undertaken to interrogate the robustness of the main findings.Two-step network MR and single-cell analysis were specifically designed to dissect pathway-level mediation and expression patterns of identified targets.Results: In the main analysis, genetically proxied calcium-channel blockers (odds ratio [OR]: 0.95, 95% confidence interval [CI]: 0.91-0.99,p=0.021) and vasodilator antihypertensives (OR: 0.86, 95% CI: 0.76-0.97,p=0.018) were suggestively associated with decreased risk of kidney cancer, whereas genetically proxied angiotensin-converting enzyme inhibitors (OR: 1.13, 95% CI: 1.00-1.27,p=0.043) was suggestively associated with increased risk of kidney cancer.Genetically proxied antiadrenergic agents (OR=0.94,95% CI: 0.90-0.99,p=0.021) and centrally acting antihypertensives (OR=0.93,95% CI: 0.88-0.98,p=0.010) were suggestively associated with a decreased risk of clear cell renal cell carcinoma.SMR analysis revealed that these suggestively significant associations might be driven by CACNA1C, CALM1, ACE, and LTA4H.Upon two-step network MR analyses, 10 pathways with directional consistency were identified, and the mediation proportion ranged from 3.22% to 7.12%.The influence of antihypertensive drugs on kidney cancer risk might be associated with their regulation of levels of blood cells and lipids.Single-cell analysis further revealed the expression patterns of the four identified targets in peripheral blood and tumor infiltrating immune cells.Ivyspring

Open the resolved locator · 10.7150/jca.110850

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-20 12:19 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://www.jcancer.org/v16p2690.htm
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.